Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Patient Derived Xenograft / PDX Models
... reach US$1.0 Billion by 2030, growing at a CAGR of 14.3% over the analysis period 2024-2030. Mice PDX Models, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and ... Read More
-
Renal Denervation Technologies
... at a CAGR of 41.7% over the analysis period 2024-2030. Radiofrequency Based, one of the segments analyzed in the report, is expected to record a 41.3% CAGR and reach US$2.1 Billion by the end of ... Read More
-
Nephrology And Urology Devices
... 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Dialysis Devices, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$28.9 Billion by the ... Read More
-
Ophthalmic Ultrasound Systems
... at a CAGR of 3.9% over the analysis period 2024-2030. Portable, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.4 Billion by the end of the ... Read More
-
Soft Tissue Allografts
... at a CAGR of 4.9% over the analysis period 2024-2030. Orthopedic, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of the ... Read More
-
Spinal Fusion Devices
... at a CAGR of 3.4% over the analysis period 2024-2030. Thoracolumbar Devices, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$5.8 Billion by the end of ... Read More
-
Restorative Dentistry
... CAGR of 8.5% over the analysis period 2024-2030. Restorative Materials, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$19.4 Billion by the end of the analysis ... Read More
-
Condoms
... 5.8% over the analysis period 2024-2030. Natural, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$9.2 Billion by the end of the analysis period. Growth in ... Read More
-
Sleep Apnea Diagnostic and Therapeutic Devices
... reach US$14.0 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More
-
Gastrointestinal (GI) Endoscopy Devices
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$25.5 ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics
... reach US$57.7 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Stimulant, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$47.7 ... Read More
-
Cystic Fibrosis Therapeutics
... at a CAGR of 15.2% over the analysis period 2024-2030. Medication, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$42.1 Billion by the end of the ... Read More
-
Narcolepsy Therapeutics
... CAGR of 7.1% over the analysis period 2024-2030. Narcolepsy with Cataplexy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.9 Billion by the end of the ... Read More
-
Kidney Cancer Drugs
... at a CAGR of 4.8% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$5.6 Billion by the end of ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.8 Billion ... Read More
-
Cardiology IT Workflow Solutions
... 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Cloud, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$1.1 Billion by the end ... Read More
-
Allergy Diagnostics
... CAGR of 10.0% over the analysis period 2024-2030. Assay Kits, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$4.5 Billion by the end of the analysis ... Read More
-
Polycystic Ovary Syndrome (PCOS) Treatment
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Insulin-Sensitizing Agents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.3 Billion ... Read More
-
Rheumatoid Arthritis Diagnosis Tests
... 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Diagnostic Laboratories End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$478.3 Million by ... Read More
-
Pigmentation Disorders Treatment
... at a CAGR of 5.7% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$4.5 Billion by the end of ... Read More
-
Lung Cancer Diagnostics
... at a CAGR of 7.8% over the analysis period 2024-2030. Imaging Tests, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$2.3 Billion by the end of ... Read More
-
Cholesterol Testing
... CAGR of 4.4% over the analysis period 2024-2030. Diagnostic Centers, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$11.6 Billion by the end of the analysis ... Read More
-
Bariatric (Obesity) Surgical Devices
... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Sleeve Gastrectomy, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$3.6 Billion by the ... Read More
-
Vertebral Compression Fracture Devices
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Balloon Kyphoplasty, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the ... Read More
-
Dental Infection Control Products
... 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.3 Billion by the end ... Read More
Research Assistance
